Allows doctors to access and analyse patients' data
Medopad has raised €48M across 5 funding rounds from 3 investors, most recently a Series B round in Oct 2019. Based in London, UK; founded 2011; active in Software and Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2019-10-01 | Series B | €23M | Bayer | View deal → |
| 2018-01-01 | Other | €23M | NWS Holdings | View deal → |
| 2014-03-01 | Seed | €507k | Vodafone | View deal → |
| 2013-06-01 | Other | €900k | — | View deal → |
| 2012-01-01 | Other | €1.0M | — | View deal → |
